Healables, with a valuation of $29.27 million, is raising funds on Dalmore Group. The company has developed personalized technology to turn down pain and turn up performance using wearables and without any medication. Healables device is currently undergoing trials on patients with knee osteoarthritis and is planned to be continued on patients with diabetic neuropathy and fibromyalgia. The company has already licensed its technology, obtained a CE mark, has been granted patents, and has signed LOIs and NDAs with multiple companies. Moshe Lebowitz founded Healables in June 2022. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $4.8 million. The campaign proceeds will be used for research and development, general and administrative expenses, marketing and sales, licensing and royalties, clinical trials and pilots, inventory, debt repayment, and working capital.